Literature DB >> 23827028

Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.

J I Ebonwu1, K S Tint, C Ihekweazu.   

Abstract

SETTING: Gauteng, South Africa.
OBJECTIVE: To determine treatment uptake among newly diagnosed multidrug-resistant tuberculosis (MDR-TB) patients and risk markers for non-initiation of treatment.
DESIGN: A cross-sectional study was conducted including all newly diagnosed MDR-TB patients in Gauteng Province, South Africa, in 2011. Socio-demographic and clinical characteristics of those who attended Sizwe Hospital, the designated MDR-TB hospital, were extracted from their medical records. District health offices provided data on patients not seen at Sizwe Hospital. Univariate and multivariate analysis were used to determine risk markers for non-initiation of treatment.
RESULTS: Of the 942 newly diagnosed MDR-TB patients in Gauteng, only 593 (63%) initiated treatment. Of these, 70 (11.8%) did not maintain treatment up to the fourth month. Among the 349 (37%) who did not initiate treatment, 31.2% died and 46.4% could not be accounted for. Referral for laboratory diagnosis from hospitals, health district of the laboratory diagnosis, human immunodeficiency virus infection and place of residence were independently associated with non-initiation of MDR-TB treatment.
CONCLUSION: Untreated patients continue to transmit MDR-TB in the community. These study findings highlight the need to identify and target the causes of non-initiation of treatment in specific settings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23827028     DOI: 10.5588/ijtld.13.0071

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  12 in total

1.  Drug-resistant tuberculosis control in South Africa: scientific advances and health system strengthening are complementary.

Authors:  Nesri Padayatchi; Marian Loveday; Naressa Naidu
Journal:  Expert Opin Pharmacother       Date:  2014-10       Impact factor: 3.889

2.  Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.

Authors:  H D Shewade; K S Shringarpure; M Parmar; N Patel; S Kuriya; S Shihora; N Ninama; N Gosai; R Khokhariya; C Popat; H Thanki; B Modi; P Dave; R K Baxi; A M V Kumar
Journal:  Public Health Action       Date:  2018-06-21

Review 3.  Availability and quality of routine morbidity data: review of studies in South Africa.

Authors:  Rifqah A Roomaney; Victoria Pillay-van Wyk; Oluwatoyin F Awotiwon; Edward Nicol; Jané D Joubert; Debbie Bradshaw; Lyn A Hanmer
Journal:  J Am Med Inform Assoc       Date:  2017-04-01       Impact factor: 4.497

4.  Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa.

Authors:  Helen S Cox; Johnny F Daniels; Odelia Muller; Mark P Nicol; Vivian Cox; Gilles van Cutsem; Sizulu Moyo; Virginia De Azevedo; Jennifer Hughes
Journal:  Open Forum Infect Dis       Date:  2015-02-26       Impact factor: 3.835

Review 5.  Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.

Authors:  R Boyd; N Ford; P Padgen; H Cox
Journal:  Int J Tuberc Lung Dis       Date:  2017-11-01       Impact factor: 2.373

Review 6.  Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youth.

Authors:  Brittney J Sullivan; B Emily Esmaili; Coleen K Cunningham
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

7.  Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.

Authors:  Pyae Phyo Wai; Hemant Deepak Shewade; Nang Thu Thu Kyaw; Saw Thein; Aung Si Thu; Khine Wut Yee Kyaw; Nyein Nyein Aye; Aye Mon Phyo; Htet Myet Win Maung; Kyaw Thu Soe; Si Thu Aung
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review.

Authors:  Charity Oga-Omenka; Azhee Tseja-Akinrin; Paulami Sen; Muriel Mac-Seing; Aderonke Agbaje; Dick Menzies; Christina Zarowsky
Journal:  BMJ Glob Health       Date:  2020-07

9.  Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.

Authors:  E Marais; C K Mlambo; J J Lewis; N Rastogi; T Zozio; M P Grobusch; A Duse; T Victor; R W Warren
Journal:  Infection       Date:  2013-12-21       Impact factor: 3.553

10.  A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.

Authors:  Pren Naidoo; Elizabeth du Toit; Rory Dunbar; Carl Lombard; Judy Caldwell; Anne Detjen; S Bertel Squire; Donald A Enarson; Nulda Beyers
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.